168427-74-5,
2'-O-(2-Methoxyethyl)adenosine,
(2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-ol,
2'-O-MOE-ADENOSINE,
Adenosine, 2'-O-(2-methoxyethyl)-,
UNII-CPN45E0H91,
CPN45E0H91,
2'-O-(2-Methoxyethyl)-adenosine,
AK103009,
2'-o-methoxyethyl adenosine,
SCHEMBL1060588,
CTK4D2995,
DTXSID70464559,
2\'-O-(2-Methoxyethyl)adenosine,
2'-O-(2-Methoxye thyl)-adenosine,
ANW-65194,
MFCD02682961,
ZINC15657781,
AKOS016005116,
AC-9546,
ACN-040829,
DS-2498,
MP-1907,
AJ-67772,
AN-31027,
CJ-15198,
AB0069364,
AX8234548,
DB-064687,
ST24020268,
Z4268,
J-700310,
(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)oxolan-3-ol,
(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-ol,
C13H19N5O5,
2/'-O-(2-Methoxyethyl)adenosine,
CID11393191,
2'-O-(2-Methoxyethyl)adenosine, 97% - 250MG 250mg,
(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)oxolan-3-ol,